Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
59
ECG Quote, Financials, Valuation and Earnings
Last price:
$69.19
Seasonality move
:
--
Day range:
$65.97 - $69.70
52-week range:
$31.38 - $77.93
Dividend yield:
0%
P/E ratio:
23.29x
P/S ratio:
1.16x
P/B ratio:
7.68x
Volume:
487.6K
Avg. volume:
343K
1-year change:
--
Market cap:
$3.5B
Revenue:
$2.8B
EPS (TTM):
$2.97
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $2.1B | $2.7B | $2.9B | $2.8B | |
| Revenue Growth (YoY) | -- | -- | 31.57% | 5.75% | -0.17% | |
| Cost of Revenues | -- | $1.8B | $2.4B | $2.5B | $2.5B | |
| Gross Profit | -- | $247.9M | $276M | $321.9M | $339.5M | |
| Gross Profit Margin | -- | 12.09% | 10.23% | 11.28% | 11.91% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $102.2M | $111.4M | $131.4M | $149.5M | |
| Other Inc / (Exp) | -- | $1.7M | $1.4M | $4M | $4.9M | |
| Operating Expenses | -- | $102.2M | $111.4M | $131.4M | $149.5M | |
| Operating Income | -- | $145.8M | $164.6M | $190.5M | $189.9M | |
| Net Interest Expenses | -- | $3.5M | $6.4M | $17M | $14M | |
| EBT. Incl. Unusual Items | -- | $144M | $159.7M | $177.6M | $180.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $35.4M | $40.8M | $45.3M | $49.5M | |
| Net Income to Company | -- | $109.4M | $124.8M | $137.2M | $143.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | $109.4M | $124.8M | $137.2M | $143.4M | |
| Basic EPS (Cont. Ops) | -- | $2.15 | $2.45 | $2.69 | $2.81 | |
| Diluted EPS (Cont. Ops) | -- | $2.15 | $2.45 | $2.69 | $2.81 | |
| Weighted Average Basic Share | -- | $51M | $51M | $51M | $51M | |
| Weighted Average Diluted Share | -- | $51M | $51M | $51M | $51.1M | |
| EBITDA | -- | $167.8M | $187.5M | $217.7M | $220.1M | |
| EBIT | -- | $147.5M | $166M | $194.5M | $194.8M | |
| Revenue (Reported) | -- | $2.1B | $2.7B | $2.9B | $2.8B | |
| Operating Income (Reported) | -- | $145.8M | $164.6M | $190.5M | $189.9M | |
| Operating Income (Adjusted) | -- | $147.5M | $166M | $194.5M | $194.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $625.7M | $826.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | 32.12% | |
| Cost of Revenues | -- | -- | -- | $551M | $734.1M | |
| Gross Profit | -- | -- | -- | $74.7M | $92.5M | |
| Gross Profit Margin | -- | -- | -- | 11.94% | 11.19% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $35.8M | $41.5M | |
| Other Inc / (Exp) | -- | -- | -- | $918K | $567K | |
| Operating Expenses | -- | -- | -- | $35.8M | $41.5M | |
| Operating Income | -- | -- | -- | $38.9M | $51M | |
| Net Interest Expenses | -- | -- | -- | $2.7M | $4.7M | |
| EBT. Incl. Unusual Items | -- | -- | -- | $37.1M | $46.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $10M | $13.6M | |
| Net Income to Company | -- | -- | -- | $28.2M | $36.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | $28.2M | $36.7M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | $0.55 | $0.72 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | $0.55 | $0.72 | |
| Weighted Average Basic Share | -- | -- | -- | $51M | $51M | |
| Weighted Average Diluted Share | -- | -- | -- | $51M | $51.1M | |
| EBITDA | -- | -- | -- | $45.8M | $58.4M | |
| EBIT | -- | -- | -- | $39.8M | $51.6M | |
| Revenue (Reported) | -- | -- | -- | $625.7M | $826.6M | |
| Operating Income (Reported) | -- | -- | -- | $38.9M | $51M | |
| Operating Income (Adjusted) | -- | -- | -- | $39.8M | $51.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $2.7B | $3.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $2.4B | $2.7B | |
| Gross Profit | -- | -- | -- | $328.7M | $357.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $134.5M | $155.2M | |
| Other Inc / (Exp) | -- | -- | -- | $4.2M | $4.5M | |
| Operating Expenses | -- | -- | -- | $134.5M | $155.2M | |
| Operating Income | -- | -- | -- | $194.2M | $202M | |
| Net Interest Expenses | -- | -- | -- | $15.9M | $16M | |
| EBT. Incl. Unusual Items | -- | -- | -- | $182.5M | $190.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $47M | $53.1M | |
| Net Income to Company | -- | -- | -- | -- | $151.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | $139.4M | $151.9M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | $2.74 | $2.98 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | $2.74 | $2.97 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | $216.3M | $232.7M | |
| EBIT | -- | -- | -- | $198.4M | $206.5M | |
| Revenue (Reported) | -- | -- | -- | $2.7B | $3.1B | |
| Operating Income (Reported) | -- | -- | -- | $194.2M | $202M | |
| Operating Income (Adjusted) | -- | -- | -- | $198.4M | $206.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $625.7M | $826.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $551M | $734.1M | |
| Gross Profit | -- | -- | -- | $74.7M | $92.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $35.8M | $41.5M | |
| Other Inc / (Exp) | -- | -- | -- | $918K | $567K | |
| Operating Expenses | -- | -- | -- | $35.8M | $41.5M | |
| Operating Income | -- | -- | -- | $38.9M | $51M | |
| Net Interest Expenses | -- | -- | -- | $2.7M | $4.7M | |
| EBT. Incl. Unusual Items | -- | -- | -- | $37.1M | $46.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $10M | $13.6M | |
| Net Income to Company | -- | -- | -- | $28.2M | $36.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | $28.2M | $36.7M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | $0.55 | $0.72 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | $0.55 | $0.72 | |
| Weighted Average Basic Share | -- | -- | -- | $51M | $51M | |
| Weighted Average Diluted Share | -- | -- | -- | $51M | $51.1M | |
| EBITDA | -- | -- | -- | $45.8M | $58.4M | |
| EBIT | -- | -- | -- | $39.8M | $51.6M | |
| Revenue (Reported) | -- | -- | -- | $625.7M | $826.6M | |
| Operating Income (Reported) | -- | -- | -- | $38.9M | $51M | |
| Operating Income (Adjusted) | -- | -- | -- | $39.8M | $51.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $2.1M | $1.6M | $86M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | $573.5M | $452.3M | $589M | |
| Inventory | -- | -- | $36.8M | $42.7M | $43.8M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | $13.3M | $17.7M | $30.4M | |
| Total Current Assets | -- | -- | $788.1M | $729.3M | $917.2M | |
| Property Plant And Equipment | -- | -- | $163.2M | $169.3M | $201.5M | |
| Long-Term Investments | -- | -- | $3.4M | $8.4M | $21.3M | |
| Goodwill | -- | -- | $143.2M | $143.2M | $143.2M | |
| Other Intangibles | -- | -- | $4.1M | $2M | $116K | |
| Other Long-Term Assets | -- | -- | $11.2M | $272K | $5.2M | |
| Total Assets | -- | -- | $1.1B | $1.1B | $1.3B | |
| Accounts Payable | -- | -- | $138.9M | $116.6M | $138.1M | |
| Accrued Expenses | -- | -- | $50.8M | $48.3M | $52M | |
| Current Portion Of Long-Term Debt | -- | -- | $27M | -- | $15M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $20M | $21.1M | $26.4M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $473.7M | $394.1M | $513.4M | |
| Long-Term Debt | -- | -- | $224.1M | $168.5M | $280.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $753.3M | $603.6M | $865.9M | |
| Common Stock | -- | -- | $1K | $1K | $510K | |
| Other Common Equity Adj | -- | -- | -$35K | -- | -- | |
| Common Equity | -- | -- | $382.2M | $448.9M | $422.6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $382.2M | $448.9M | $422.6M | |
| Total Liabilities and Equity | -- | -- | $1.1B | $1.1B | $1.3B | |
| Cash and Short Terms | -- | -- | $2.1M | $1.6M | $86M | |
| Total Debt | -- | -- | $251.1M | $168.5M | $295.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | $54.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | $590.7M | |
| Inventory | -- | -- | -- | -- | $47.4M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | $34.8M | |
| Total Current Assets | -- | -- | -- | -- | $971M | |
| Property Plant And Equipment | -- | -- | -- | -- | $213.5M | |
| Long-Term Investments | -- | -- | -- | -- | $23.5M | |
| Goodwill | -- | -- | -- | -- | $143.2M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | $4.6M | |
| Total Assets | -- | -- | -- | -- | $1.4B | |
| Accounts Payable | -- | -- | -- | -- | $182.3M | |
| Accrued Expenses | -- | -- | -- | -- | $56.9M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $15M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $27.8M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | $545.9M | |
| Long-Term Debt | -- | -- | -- | -- | $277.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | $895.6M | |
| Common Stock | -- | -- | -- | -- | $510K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | $460.2M | |
| Total Liabilities and Equity | -- | -- | -- | -- | $1.4B | |
| Cash and Short Terms | -- | -- | -- | -- | $54.3M | |
| Total Debt | -- | -- | -- | -- | $292.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $109.4M | $124.8M | $137.2M | $143.4M | |
| Depreciation & Amoritzation | -- | $20.3M | $21.5M | $23.1M | $25.3M | |
| Stock-Based Compensation | -- | $1.7M | $1.1M | $804K | $1.6M | |
| Change in Accounts Receivable | -- | -$12.8M | -$235.1M | $45.3M | -$89.7M | |
| Change in Inventories | -- | -$2.1M | -$15.8M | -$5.9M | -$1M | |
| Cash From Operations | -- | $85.4M | -$25.5M | $171.3M | $163.4M | |
| Capital Expenditures | -- | $27.3M | $35.8M | $35.6M | $48.3M | |
| Cash Acquisitions | -- | -$2.5M | -- | -- | -- | |
| Cash From Investing | -- | $924K | -$24.6M | -$20M | -$37.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $27M | -- | $340M | |
| Long-Term Debt Repaid | -- | -$7K | -- | -$72M | -$40M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$87.8M | $24.5M | -$79.9M | -$341.9M | |
| Cash From Financing | -- | -$87.8M | $51.5M | -$151.9M | -$41.9M | |
| Beginning Cash (CF) | -- | $2.1M | $668K | $2.1M | $1.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$1.4M | $1.4M | -$545K | $84.4M | |
| Ending Cash (CF) | -- | $668K | $2.1M | $1.6M | $86M | |
| Levered Free Cash Flow | -- | $58.2M | -$61.3M | $135.7M | $115.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $28.2M | $36.7M | |
| Depreciation & Amoritzation | -- | -- | -- | $6M | $6.9M | |
| Stock-Based Compensation | -- | -- | -- | $344K | $1.7M | |
| Change in Accounts Receivable | -- | -- | -- | -$15.9M | -$55.9M | |
| Change in Inventories | -- | -- | -- | -$937K | -$3.7M | |
| Cash From Operations | -- | -- | -- | $21.9M | $7.1M | |
| Capital Expenditures | -- | -- | -- | $9.2M | $18.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$6.4M | -$14.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$3.8M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$16.5M | -$588K | |
| Cash From Financing | -- | -- | -- | -$16.5M | -$4.3M | |
| Beginning Cash (CF) | -- | -- | -- | $1.6M | $86M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$1M | -$12M | |
| Ending Cash (CF) | -- | -- | -- | $543K | $74M | |
| Levered Free Cash Flow | -- | -- | -- | $12.6M | -$11.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | $151.9M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $26.2M | |
| Stock-Based Compensation | -- | -- | -- | $344K | $3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -$129.6M | |
| Change in Inventories | -- | -- | -- | -- | -$3.8M | |
| Cash From Operations | -- | -- | -- | -- | $148.6M | |
| Capital Expenditures | -- | -- | -- | $9.2M | $57.6M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -$45.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$43.8M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$326M | |
| Cash From Financing | -- | -- | -- | -- | -$29.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | $73.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | $91.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $28.2M | $36.7M | |
| Depreciation & Amoritzation | -- | -- | -- | $6M | $6.9M | |
| Stock-Based Compensation | -- | -- | -- | $344K | $1.7M | |
| Change in Accounts Receivable | -- | -- | -- | -$15.9M | -$55.9M | |
| Change in Inventories | -- | -- | -- | -$937K | -$3.7M | |
| Cash From Operations | -- | -- | -- | $21.9M | $7.1M | |
| Capital Expenditures | -- | -- | -- | $9.2M | $18.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$6.4M | -$14.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$3.8M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$16.5M | -$588K | |
| Cash From Financing | -- | -- | -- | -$16.5M | -$4.3M | |
| Beginning Cash (CF) | -- | -- | -- | $1.6M | $86M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$1M | -$12M | |
| Ending Cash (CF) | -- | -- | -- | $543K | $74M | |
| Levered Free Cash Flow | -- | -- | -- | $12.6M | -$11.4M | |
Get ECG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ECG
Sector
P/E ratio
23.29x
18.58x
PEG ratio
2.69x
0.25x
P/B ratio
7.68x
1.75x
Price / LTM sales
1.16x
0.94x
Growth Metrics
ECG
Sector
Revenue growth
32.12%
1.98%
Earnings growth
30.08%
2.46%
Revenue (5-year growth)
--
4.35%
Earnings forecast
$0.62
$0.40
Profitability
ECG
Sector
Profitability FY 2024
$339.5M
$393.9M
Return on invested capital
21.13%
5.32%
Return on assets
11.68%
3.49%
Return on equity
34.75%
8.55%
Earnings Date
Last Earnings Date
May
14
Next Earnings Date
Aug
29
Estimated Next Earnings Date
Aug
13
Balance Sheet
ECG
Sector
Total cash
$54.3M
$154.3M
Short term investments
--
$35.5M
Total assets
$1.3B
$1.7B
Long term debt
$292.1M
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
